Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 144 for Ovarian

Edit search filters
  1. Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. The Role Of Cytomegalovirus And Inflammation On Patient Symptoms And Outcomes In Ovarian Cancer

    Albert Lea, MN, Mankato, MN

  3. A Study To Learn About How Women Metabolize And Respond To Opioids When Used For Managing Post-operative Pain

    Rochester, MN

  4. A Study To Assess Dynamic Changes In Plasma Proteome To Identify Early Detection And Treatment Response Biomarkers For HGSOC

    Rochester, MN

  5. Investigations Of Reproductive Cancers In Women (PROACTION:)

    Rochester, MN

  6. ADVANCE

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. ADVANCE 2: ADdressing Views Of African AmericaNs On CancEr Screening

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Use of Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy and Risk of Malignancy in Genetic Mutation Carriers

    Rochester, MN

  9. Ovarian Cancer Microbiome Signatures

    Rochester, MN

  10. A Study to Evaluate Blood Chemistry, Genetics, and Eye Exams in Women with Polycystic Ovary Syndrome and/or Idiopathic Intracranial Hypertension

    Rochester, MN

.

Mayo Clinic Footer